Hepatic complications of erythropoietic protoporphyria

1 KIlis CN. Fradin MS. Mcssiirui JM rt til. Cyclosporine lor plaquc-typt' psoriasis. N F.niil / Med 1991; 524: 2 77-84. 2 De Rie MA. Meinardi MMHM. Bos |D. Analysis of side-t-ffects of mediumand low-dose cyclosporin maintenance therapy in psoriasis. Br I Dcrmiitol 1990: 12i: i47-S5. i Kahan BLl Cyclosporinf. Mlnql I Med 1989: U\: 172S-i8. 4 Sherman Ml. Rctimmh and Cell Diffi-rnnialion (Shearnum MI. ed.l. lJoca Rafon: CRC Press, 198f); I 78. 5 Hiilioua B, Saurat )ll. Risk: benelit ratio in the treatment of psoriasis with syslemif retinoids. Br j Dcriimlol 1990: 122 (Suppi. i()|: 155-5(1. (•> Korstanje MJ, van de Staak W'|BM. Combination-therapy cyclosporin-A-etretin ale for psoriasis. Cliu F.xp DiTmatoI 1990: 15: 172-J. 7 Meinardi MMHM. Bos ji). Cyelosporine mainlenanatherapy in psoriasis. Tniiisiylnnl I'nx19S8: 20(SLipp!. 4): 42-9. 8 Fry L, Griflitbs i.TM. Povvies AV a itl. Long-term cyclosporine in the management ol psoriasis. Tnuisplniit Proc 1988: 20 (Suppi. 4(: i }-5. 9 Webber IR. Back D|. Effect ol'etretinate on eyclosporin metabolism in vitro. HrlDermatol 199i: 128:42-4.

[1]  E. Trimble,et al.  Erythropoietic protoporphyria and iron therapy , 1990, The British journal of dermatology.

[2]  J. van Hattum,et al.  Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatement , 1990, Hepatology.

[3]  J. A. Johnson,et al.  Prognosis of liver transplantation in patients with erythropoietic protoporphyria. , 1989, Transplantation.

[4]  M. Doss,et al.  Hepatobiliary implications and complications in protoporphyria, a 20-year study. , 1989, Clinical biochemistry.

[5]  H. Baker,et al.  Erythropoietic protoporphyria exacerbated by oral iron therapy , 1988, The British journal of dermatology.

[6]  J. Bloomer.  The liver in protoporphyria , 1988, Hepatology.

[7]  M. C. Park,et al.  Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. , 1988, Gastroenterology.

[8]  G. Brittenham,et al.  Iron therapy for hepatic dysfunction in erythropoietic protoporphyria. , 1986, Annals of internal medicine.

[9]  J. Bloomer,et al.  Effect of hematin administration to patients with protoporphyria and liver disease , 1982, Hepatology.

[10]  J. Bloomer.  THE YALE JOURNAL OF BIOLOGY AND MEDICINE 52 (1979), 39-48 Pathogenesis and Therapy of Liver Disease in Protoporphyria , 1978 .

[11]  M. Mathews-Roth,et al.  Erythropoietic protoporphyria. 10 years experience. , 1976, The American journal of medicine.

[12]  Stathers Gm.  PORPHYRIN-BINDING EFFECT OF CHOLESTYRAMINE , 1966 .

[13]  G. Stathers.  Porphyrin-binding effect of cholestyramine. Results of in-vitro and in-vivo studies. , 1966, Lancet.